Will Amazon, Berkshire Hathaway and JPMorgan Chase deliver patient-centered reforms?
Last month, Amazon, Berkshire Hathaway and JPMorgan Chase announced plans to launch a joint venture
John
February 28, 2018
Author: John
Pharmacy Benefit Managers restrict access for patients living with a chronic disease
As most of you know, living with a chronic disease is challenging at best and
John
February 20, 2018
Aetna Medical Director Admits To Never Reviewing Medical Records Before Denying Care: What Every Patient Should Know
A former medical director at insurance giant Aetna admitted under oath that he never reviewed
John
February 14, 2018
Anthem: Insurance company refusing to cover emergency room visits
The largest insurance company in the country is refusing to cover patient visits to the
John
February 13, 2018
Public Input Welcome on the Open-Source Value Project
You have until February 16th to comment on the IVI value model for rheumatoid arthritis.
John
February 12, 2018
PATIENT STORY SHOWS WHY WE NEED THE CANCER ORAL DRUG COVERAGE PARITY ACT OF 2017
A Milwaukee TV station recently shared the story of a patient that’s been “punched in
John
February 9, 2018
Arizona: Patients Rising joins coalition calling for patient access amendments to opioid reform legislation
Governor Doug Ducey recently signed major legislation that would change the way that patients access pain
John
February 7, 2018
The RAConnection Expands its Mission to Include Psoriatic Arthritis, Ankylosing Spondylitis, Lupus, Osteoporosis and Wellness
In order to meet the changing ways that patients access information and community, a new
John
February 4, 2018
PBM: Pharmacy Benefit Managers forbid pharmacists from telling patients how to save money
There’s a secret you should know about that could help lower the price you pay
John
January 30, 2018
Medical Bills: How I reduced my medical costs and avoided going into debt
I started 2018 with medical debt resulting from emergency surgery I had last October. But,
John
January 29, 2018
ICER Draft Evidence Report on Chimeric Antigen Receptor T-Cell Therapy for B-Cell Cancers
We appreciate the opportunity ICER allows for stakeholders, including patient advocates and patients themselves, to
John
January 25, 2018
Insurers don’t pay full price for medications, why should you?
If you found out that there was an unregulated part of the healthcare system that
John
January 24, 2018
